Otsuka Pharma GmbH
- Pharmaceutical Sales 2010
-
Worldwide: 9.73 billion Euro
(fiscal year 04/2009 - 03/2010)
In Germany: 86 million Euro
- Product Range
- cardiovascular (PaVK) in co-promotion, central nervous system disorders (schizophrenia, bipolar disorsers) in co-promotion, gastrointestinal and ulcerative colitis and Crohn’s Disease (medical device), hyponatraemia secondary to SIADH
- Key Research Areas
- respiratory system, ophthalmology, cardiovascular area, oncology, central nervous system, parkinson, central nervous system disorders, tuberculosis, gastroenterology, dermatology, infectious diseases
- R&D Expenditure 2010
-
Worldwide: 1.4 billion US-Dollars
(fiscal year 04/2009 - 03/2010)
In Germany: n/a
- Employees in the Pharmaceuticals Division 2010
-
worldwide: 36,000
In Germany: 83
(All data based on corporate information, as of: 06/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page